Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7859

1.

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.

Klug LR, Bannon AE, Javidi-Sharifi N, Town A, Fleming WH, VanSlyke JK, Musil LS, Fletcher JA, Tyner JW, Heinrich MC.

Oncogene. 2018 Sep 21. doi: 10.1038/s41388-018-0508-5. [Epub ahead of print]

PMID:
30242244
2.

An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor.

Ravegnini G, Urbini M, Simeon V, Genovese C, Astolfi A, Nannini M, Gatto L, Saponara M, Ianni M, Indio V, Brandi G, Trino S, Hrelia P, Biasco G, Angelini S, Pantaleo MA.

Pharmacogenomics J. 2018 Sep 20. doi: 10.1038/s41397-018-0050-4. [Epub ahead of print]

PMID:
30237583
3.

Perforated gastrointestinal stromal tumor in the small intestine: A rare case of Torricelli-Bernoulli sign.

Tajima T, Nishi T, Tomioku M, Ogimi T, Chan LF, Okazaki T, Myoujin K, Shimada H.

Mol Clin Oncol. 2018 Oct;9(4):399-402. doi: 10.3892/mco.2018.1699. Epub 2018 Aug 16.

PMID:
30233793
4.

Endoscopic selective muscular dissection for gastric submucosal tumor.

Esaki M, Suzuki S, Gotoda T.

Dig Endosc. 2018 Sep 19. doi: 10.1111/den.13277. [Epub ahead of print]

PMID:
30230048
5.

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib.

Bouché O, Cesne AL, Rios M, Chaigneau L, Italiano A, Duffaud F, Lecomte T, Arsène D, Manfredi S, Aparicio T, Remy S, Isambert N, Collard O, Priou F, Bertucci F, Sambuc R, Bisot-Locard S, Bourges O, Chabaud S, Blay JY.

PLoS One. 2018 Sep 18;13(9):e0204117. doi: 10.1371/journal.pone.0204117. eCollection 2018.

6.

Pediatric gastrointestinal stromal tumors-a review of diagnostic modalities.

Quiroz HJ, Willobee BA, Sussman MS, Fox BR, Thorson CM, Sola JE, Perez EA.

Transl Gastroenterol Hepatol. 2018 Aug 8;3:54. doi: 10.21037/tgh.2018.07.08. eCollection 2018. Review.

7.

Current treatment strategies in pediatric gastrointestinal stromal cell tumor.

Willobee BA, Quiroz HJ, Sussman MS, Thorson CM, Sola JE, Perez EA.

Transl Gastroenterol Hepatol. 2018 Aug 8;3:53. doi: 10.21037/tgh.2018.07.09. eCollection 2018. Review.

8.

Genomic Subtypes of GISTs for Stratifying Patient Response to Sunitinib following Imatinib Resistance: A Pooled Analysis and Systematic Review.

Tan S, Chen P, Ji J, Guo S, Yu D, Asakawa T, Zhou Y, Abe M, Zong L.

Dis Markers. 2018 Aug 26;2018:1368617. doi: 10.1155/2018/1368617. eCollection 2018. Review.

9.

Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.

Wang WJ, Li HT, Yu JP, Li YM, Han XP, Chen P, Yu WW, Chen WK, Jiao ZY, Liu HB.

Mol Med Rep. 2018 Sep 5. doi: 10.3892/mmr.2018.9457. [Epub ahead of print]

PMID:
30221743
10.

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.

Mir O, Azaro A, Merchan J, Chugh R, Trent J, Rodon J, Ohnmacht U, Diener JT, Smith C, Yuen E, Oakley GJ 3rd, Le Cesne A, Soria JC, Benhadji KA, Massard C.

Eur J Cancer. 2018 Sep 12;103:88-97. doi: 10.1016/j.ejca.2018.08.012. [Epub ahead of print]

PMID:
30218977
11.

GISToscopy.

Zimmer V, Lammert F.

Clin Case Rep. 2018 Jul 23;6(9):1903-1904. doi: 10.1002/ccr3.1695. eCollection 2018 Sep.

12.

Correction to: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.

Hu F, Li H, Liu L, Xu F, Lai S, Luo X, Hu J, Yang X.

Mol Cancer. 2018 Sep 13;17(1):135. doi: 10.1186/s12943-018-0885-y.

13.

Endoscopic Submucosal Dissection for Gastric-phenotype Adenoma on the Surface of Gastric Gastrointestinal Stromal Tumor.

Yamamoto S, Nishimura N, Mizuno M, Shimodate Y, Doi A, Mouri H, Matsueda K, Yamamoto H.

Intern Med. 2018 Sep 12. doi: 10.2169/internalmedicine.1122-18. [Epub ahead of print]

14.
15.

A Case Report of Synchronous Prostate Cancer and Rectal Gastrointestinal Stromal Tumor and its Management.

Watanabe R, Ozawa A, Iseda T, Hatano H.

Urol J. 2018 Sep 11. doi: 10.22037/uj.v0i0.3834. [Epub ahead of print]

16.

Discovery of N-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide (AZD3229), a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.

Kettle JG, Anjum R, Barry E, Bhavsar D, Brown C, Boyd S, Campbell A, Goldberg K, Grondine M, Guichard S, Hardy C, Hunt T, Jones R, Li X, Moleva O, Ogg D, Overman R, Packer MJ, Pearson S, Schimpl M, Shao W, Smith A, Smith J, Stead D, Stokes S, Tucker M, Ye Y.

J Med Chem. 2018 Sep 11. doi: 10.1021/acs.jmedchem.8b00938. [Epub ahead of print]

PMID:
30204441
17.

Gastrointestinal Stromal Tumors with KIT Mutation Coexisting with Wild-type Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1.

Li Y, Gao ZD, Yang XD, Ye YJ, Wang S, Jiang KW.

Chin Med J (Engl). 2018 Sep 20;131(18):2244-2245. doi: 10.4103/0366-6999.240814. No abstract available.

18.

The prepurse-string suture technique for gastric defect after endoscopic full-thickness resection (with video).

Wu N, Liu S, Chen M, Zeng X, Wang F, Zhang J, She Q.

Medicine (Baltimore). 2018 Sep;97(36):e12118. doi: 10.1097/MD.0000000000012118.

19.

Successful treatment of metastatic mucosal melanoma with a Del579 c-KIT mutation by imatinib after treatment of anti-PD-1 antibody.

Yamashita C, Otsuka A, Nomura M, Honda T, Kabashima K.

J Eur Acad Dermatol Venereol. 2018 Sep 10. doi: 10.1111/jdv.15246. [Epub ahead of print]

PMID:
30199578
20.

Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer.

Xian HP, Zhuo ZL, Sun YJ, Liang B, Zhao XT.

Oncol Lett. 2018 Oct;16(4):4689-4698. doi: 10.3892/ol.2018.9199. Epub 2018 Jul 24.

Supplemental Content

Loading ...
Support Center